| Patents for A61K 41 - Medicinal preparations obtained by treating materials with wave energy or particle radiation (9,445) |
|---|
| 05/18/2006 | US20060104898 Targeting ligands comprising an amino acid sequence for guided targeting of irradiated glioma, a melanoma, and a lung carcinoma |
| 05/17/2006 | EP1007729A4 COMPLEX FORMATION BETWEEN dsDNA AND OLIGOMER OF HETEROCYCLES |
| 05/16/2006 | US7045117 Method for tumor diagnosis comprising administering of palladium-substituted bacteriochlorophyll derivatives |
| 05/11/2006 | WO2006048633A2 Combination comprising zd6474 and an antiandrogen |
| 05/11/2006 | WO2006047868A1 Method of treating microorganisms in the oral cavity via photodynamic therapy employing a non-coherent light source |
| 05/11/2006 | WO2005034912A3 Ferromagnetic particles and methods |
| 05/11/2006 | CA2583570A1 Combination comprising zd6474 and an antiandrogen |
| 05/10/2006 | EP1653992A1 Use of a vegf antagonist in combination with radiation therapy |
| 05/10/2006 | EP1653972A1 Topical use of tyrosine kinase inhibitors of microbial origin to prevent and treat skin disorders characterised by excessive cell proliferation |
| 05/10/2006 | EP1653967A2 Combination of a cox-2 inhibitor and an alkylating-type antineoplastic agent for treatment of neoplasia |
| 05/10/2006 | EP1653964A1 Cancer combination therapy comprising azd2171 and zd1839 |
| 05/10/2006 | EP1653940A1 Therapeutic combination of a cox-2 inhibitor and an aromatase inhibitor |
| 05/09/2006 | USRE39094 absorb light further in the red, optimizing tissue penetration and are retained in the skin for short time periods relative to other drugs used in photodynamic cancer therapy |
| 05/09/2006 | US7041653 Gene transcription and ionizing radiation: methods and compositions |
| 05/09/2006 | US7041241 Microspheres contain 5-fluorouracil coated with poly(d-l-lactic acid-co-glycolic acid); implanted in walls of operation site following exeresis of tumor, by intratissular injection |
| 05/04/2006 | WO2006047080A1 Presbyopia treatment by lens alteration |
| 05/04/2006 | WO2006013227A8 Methylamine risks and treatment with n-derivatives of hyperactivity, depression and alcoholism |
| 05/04/2006 | WO2005110395A8 System and device for magnetic drug targeting with magnetic drug carrier particles |
| 05/04/2006 | WO2005089398A3 Method for the delivery of sustained release agents |
| 05/04/2006 | WO2005048944A3 Activatable photodynamic therapy agents |
| 05/04/2006 | US20060095101 Treatment of pigmented tissues using optical energy |
| 05/04/2006 | US20060093611 from mammalian chondrocyte progenitor cells expressing mechanosensitive TWIK-related potassium (TREK) ion channels; biocompatability, in vitro |
| 05/04/2006 | CA2584879A1 Presbyopia treatment by lens alteration |
| 05/03/2006 | EP1189660B1 Apparatus for microporation of biological membranes using thin film tissue interface devices, and method therefor |
| 05/03/2006 | EP1087794B8 Light application device for photodynamic diagnosis or photodynamic therapy of diseases of the parodontium and teeth |
| 05/02/2006 | US7038041 Selective nuclear receptor-targeted systems for delivery of cytotoxins to cancer cells for targeted photodynamic therapy |
| 05/02/2006 | US7037534 Inactivation of viral infections agents by chemiluminescence activated light-sensitive compounds |
| 05/02/2006 | US7036516 Treatment of pigmented tissues using optical energy |
| 05/02/2006 | CA2486475A1 Method of treating microorganisms in the oral cavity |
| 04/27/2006 | US20060089674 Method of treating biological materials with translating electrical fields and electrode polarity reversal |
| 04/27/2006 | US20060088584 Storage stability; freeze drying; mixture containing phospholipids and monosaccharides; regenerated as aqueous solution;administering by injection |
| 04/27/2006 | US20060088530 Administering lyposomes of photosensitive receptors or ligands targeted to specific tissues, exposure to light causing destruction of bound tissues; treatment of eye neovascular disease due to macular degeneration, diabetes |
| 04/26/2006 | EP1648465A1 Use of the quinazoline derivative zd6474 combined with platinum compounds and optionally ionising radiation in the treatment of diseases associated with angiogenesis and/or increased vascular permeability |
| 04/26/2006 | CN1764602A Surface-modified titanium dioxide fine particles and dispersion comprising the same, and method for producing the same |
| 04/26/2006 | CN1764477A Devices and compositions containing boron and silicon for use in neutron capture therapy |
| 04/25/2006 | US7033829 Treating hyperproliferative disorders including cancers by administering an oligonucleotide which shares at least 50% nucleotide sequence identity with the human telomere overhang repeat. |
| 04/20/2006 | WO2006041670A2 Uv device for treating osteolysis |
| 04/20/2006 | WO2006041617A1 Biodegradable cationic polymers |
| 04/20/2006 | US20060084701 Diagnosis and treatment of cervical and bladder cancer using hexyl 5-aminolevulinate as a photosensitizer; improved photochemotherapeutic properties; antineoplastic agents |
| 04/20/2006 | US20060084697 Pi3k antagonists as radiosensitizers |
| 04/20/2006 | CA2581632A1 Biodegradable cationic polymers |
| 04/19/2006 | EP1646424A1 Magnetic particles for therapeutic treatment |
| 04/18/2006 | US7030096 transduction of DNA sequences by naked DNA transfer, expression of genes that code for muscle tone controllers; gene therapy for prophylaxis of erectile dysfunction, urogenital and muscular disorders |
| 04/13/2006 | WO2005056058A3 Radiosensitizer conjugate to improve the efficacy of radiolabeled drugs |
| 04/12/2006 | EP1645305A1 Apparatus for microporation of biological membranes using thin film tissue interface devices, and method for manufacturing |
| 04/12/2006 | EP1644728A2 Method for in vivo determination on tested animals of the efficient concentration of deuterium depleted water for cancer therapy |
| 04/12/2006 | EP1644488A1 Irradiated osteoinductive extracellular material |
| 04/12/2006 | EP1643953A2 Regulation of matrix metalloproteinase gene expression using specific and selective electrical and electromagnetic signals |
| 04/12/2006 | CN1758908A Treatment of proliferative diseases with epothilone derivatives and radiation |
| 04/12/2006 | CN1250571C Specific binding molecules for scintigraphy, conjugates containing them and uses |
| 04/12/2006 | CN1250294C Photosensitive and method for production thereof |
| 04/11/2006 | CA2317549C Composition for enhancing transport through lipid-containing membranes, and uses thereof |
| 04/06/2006 | WO2005107701A3 Remote control release of material encapsulated in polyelectrolyte multilayer microcapsules |
| 04/06/2006 | US20060073222 Saponin mixtures and compounds isolated from Acacia victoriae; glycosides of acacic or oleanolic acid; control of cell apoptosis and cytotoxicity; antitumor, -carcinogenic, -inflammatory and -proliferative agents; atherosclerosis |
| 04/06/2006 | US20060073100 Detection and therapy of vulnerable plaque with fluorescent and/or radiolabeled compositions |
| 04/06/2006 | CA2578956A1 Combination comprising zd6474 and an imatinib |
| 04/05/2006 | EP1140192B1 Use of the cyclooxygenase-2 inhibitor celecoxib and capecitabine for combination therapy in neoplasia |
| 04/05/2006 | EP0871673B1 Bispecific antibodies in which the binding capability is reversibly inhibited by a photocleavable moiety |
| 04/05/2006 | CN1756561A Immunotherapy of B cell malignancies and autoimmune diseases using unconjugated antibodies and conjugated antibodies and antibody combinations and fusion proteins |
| 04/04/2006 | US7022136 Stent for neutron capture therapy and method of manufacture therefor |
| 04/04/2006 | CA2327393C Solution for the preparation of a pharmaceutical substance for diagnosing and/or treating tissue pathologies |
| 03/30/2006 | US20060068495 Process of cell electrofusion |
| 03/30/2006 | US20060067881 Synthesis, compositions and methods for the measurement of the concentration of stable-isotope labeled compounds in life forms and life form excretory products |
| 03/29/2006 | EP1638504A1 Non-invasive intravascular thrombolyisis using modified ultrasound techniques |
| 03/29/2006 | EP1476190B1 Amino-substituted hypocrellins for use as sonosensitizers |
| 03/29/2006 | EP1251828A4 Local drug delivery using photosensitizer-mediated and electromagnetic radiation-enhanced vascular permeability |
| 03/28/2006 | US7019132 Porphyrin derivatives |
| 03/28/2006 | US7018395 to destroy or impair target cells expressing a vascular endothelial growth factor (VEGF) receptor by administering a liposome system of conjugated antibodies, conjugated photosensitizer and another liposome conjugate and using light of an intensity such that nontarget cells are not destroyed |
| 03/23/2006 | WO2005030317A3 Phototherapeutic treatment of skin conditions |
| 03/23/2006 | DE102004043279A1 Method and device for e.g. biological and pharmaceutical use of nitrosyl molecules, comprises producing metastable condition in nitrosyl complexes by electromagnetic radiation and detaching carrier complex by supplying minimum energy |
| 03/22/2006 | EP1636345A2 Methods for inducing the differentiation of monocytes into functional dendritic cells and immunotherapeutic compositions including such dendritic cells |
| 03/22/2006 | EP1635826A2 Methods and compositions using immunomodulatory compounds for treatment and management of cancers and other diseases |
| 03/22/2006 | EP1437975A4 Optically-absorbing nanoparticles for enhanced tissue repair |
| 03/22/2006 | EP1404319B1 Novel metalloporphyrins and their uses as radiosensitizers for radiation therapy |
| 03/21/2006 | US7015352 Capable of permeating a desired biological compartment and releasing a biologically active molecule in active form to effect a therapeutic functional change in the compartment to which it is introduced |
| 03/21/2006 | US7015240 Treatment of macular edema |
| 03/21/2006 | CA2443314C Method of imaging cell death in vivo |
| 03/16/2006 | WO2006027582A1 Assay methods, materials and preparations |
| 03/16/2006 | WO2005092286A3 Metallic nano-particles and discrete polymer-coated nano-particles |
| 03/16/2006 | US20060058258 Gene transcription and ionizing radiation: methods and compositions |
| 03/16/2006 | US20060057192 Localized non-invasive biological modulation system |
| 03/15/2006 | EP0952873B1 Use of a magnetic material for the manufacture of a medicament for use in targeted hysteresis hyperthermia |
| 03/14/2006 | US7011817 Hydrophilic cyanine dyes |
| 03/14/2006 | CA2409245C Method and apparatus for ion transport activation |
| 03/09/2006 | WO2005014572A8 Pyrimidylpyrrole derivatives active as kinase inhibitors |
| 03/09/2006 | WO2004069326A3 Light probe for ultraviolet light activated gene transduction |
| 03/09/2006 | US20060052583 Protein production |
| 03/09/2006 | US20060052433 Compound |
| 03/09/2006 | US20060052323 Method to inhibit cell growth using oligonucleotides |
| 03/09/2006 | US20060052319 Sensitization of cells to cytotoxic agents using oligonucleotides directed to nucleotide excision repair or transcritpion coupled repair genes |
| 03/09/2006 | US20060051321 Biological compositions and methods for treatment of testicular cancer |
| 03/08/2006 | EP1631299A2 Methods and compositions to treat myocardial conditions |
| 03/08/2006 | EP1631259A1 Otologic nanotechnology |
| 03/08/2006 | EP1631146A1 Treatment of cancer with active vitamin d compounds in combination with radiotherapeutic agents and treatments |
| 03/08/2006 | CN1744906A Auxiliary agent to be used in cancer therapy by dielectric heating and cancer therapy method |
| 03/02/2006 | WO2006022340A1 Composite fine particles and process for producing the same |
| 03/02/2006 | CA2577441E Improved photosensitizer formulations and their use |
| 03/01/2006 | EP1630136A1 Surface-modified titanium dioxide fine particles and dispersion comprising the same, and method for producing the same |
| 03/01/2006 | EP1628958A2 Amphiphilic trisulfonated porphyrazines for photodynamic applications in medicine |
| 03/01/2006 | EP1628681A1 Method of reducing the harmful effects of orally or transdermally delivered nicotine |